Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
04/2001
04/03/2001US6211432 DNA sequences coding for a cinnamoyl COA reductase, and applications thereof in the control of lignin contents in plants
04/03/2001US6211352 Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
04/03/2001US6211351 For introduction of genetic changes in eukaryotic cells
04/03/2001US6211338 Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide
04/03/2001US6211334 Cell-cycle regulatory proteins, and uses related thereto
04/03/2001US6211163 Injection; sustained release of expressed protein
04/03/2001US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus
04/03/2001US6211134 Mutant α-amylase
04/03/2001US6210966 Culture medium for insect cells lacking glutamine an contains ammonium salt
04/03/2001US6210954 Microorganism cultures; for the generation of heterologous proteins
04/03/2001US6210951 GMP synthetase and gene coding for the same
04/03/2001US6210945 Method for cloning and producing the RsaI restriction endonuclease in E. coli and purification of the recombinant RsaI restriction endonuclease
04/03/2001US6210944 Phosphoribosyl transferase from Staphylococcus aureus
04/03/2001US6210943 Sucrose phosphate synthase from citrus and DNA encoding the same
04/03/2001US6210942 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use
04/03/2001US6210940 Streptococcus protein of defined amino acid sequence having transfer rna synthetase activity; drug screening; bactericides; bacteriostats; antibodies; enzyme inhibitors
04/03/2001US6210938 Antibody catalysis of enantio- and diastereo-selective aldol reactions
04/03/2001US6210935 Dna from streptomyces which codes for polypeptide involved in biosynthesis; probing libraries; polymerase chain reaction amplifications; inhibiting biosynthesis; transformed host organisms
04/03/2001US6210934 Transaminase from escherichia coli; for efficient production of l-2-amino-4-methylphosphinobutyric acid
04/03/2001US6210933 Amino acid sequence; for adding sialic acids to glycoproteins, glycolipids, and other acceptor molecules
04/03/2001US6210929 Fusion protein of furin with catalytic center and c-terminal deletion, flexible peptide spacer, and histidine-tag affinity peptide; for proteolytic processing/activation of recombinant proteins
04/03/2001US6210920 Flea protease proteins, nucleic acid molecules, and uses thereof
04/03/2001US6210918 Detecting level of nitric oxide, arginine or citrulline, or activity or expression of nitric oxide synthase, or conversion of nitric oxide to nitrate and nitrite in sample, and comparing to non-laboring pregnant female
04/03/2001US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate
04/03/2001US6210916 Mixture of enzyme involved in cell cycle control, serine-containing substrate of the enzyme, and gamma-phosphate labeled adenosine triphosphate; for screening agonists and antagonists of enzyme
04/03/2001US6210915 Contacting cell sample with buffer which is mixture of nonionic detergent and ionic, nonzwitterionic detergent to extract the enzyme
04/03/2001US6210890 Human peroxisomal thioesterase
04/03/2001US6210685 Acellular whooping cough vaccines.
04/03/2001US6210667 Relates to modifications of streptokinase and other microbial enzymes for use to activate plasminogen in the presence of fibrin, to efficiently dissolve an unwanted blood clot in a subject.
04/03/2001US6210666 Truncated α-galactosidase A to treat fabry disease
04/03/2001US6210662 Fusion protein having prostatic acid phosphatase (pap) as an n-terminal moiety and gm-csf as a c-terminal moiety, and wherein said cells are effective to activate t-cells to produce a multivalent cytotoxic cellular immune response
04/03/2001US6210654 Jak kinases and regulation of cytokine signal transduction
04/03/2001CA2194388C Endo-1,4-.beta.-glucanase genes and their use in plants
04/03/2001CA2118043C Immortalized human cell lines containing exogenous cytochrome p450 genes
04/03/2001CA2093422F Detergent compositions containing cellulase compositions deficient in cbh i type components
04/03/2001CA2066234C Activation compounds and methods for nucleic acid sterilization
04/03/2001CA2041728C Method for the prevention of crop injury in the presence of synergistic pesticide combinations
04/01/2001CA2319168A1 Hyperactive mutants of himar1 transposase and methods for using the same
04/01/2001CA2284246A1 Plant fatty acid desaturases and alleles therefor
03/2001
03/30/2001WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
03/30/2001CA2283538A1 New hev antigenic peptide and methods
03/29/2001WO2001022090A1 Method for identifying compounds useful in the therapy of bone disorders
03/29/2001WO2001021829A1 Polynucleotides encoding human soluble adenylyl cyclase, polypeptides encoded thereby, and methods of use thereof
03/29/2001WO2001021825A2 Novel enzymes which dehydrate glycerol
03/29/2001WO2001021820A1 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
03/29/2001WO2001021817A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
03/29/2001WO2001021815A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021814A1 Heparanase-2, a member of the heparanase protein family
03/29/2001WO2001021813A1 Method and compositions for improved polynucleotide synthesis
03/29/2001WO2001021812A1 Phosphatases which activate map kinase pathways
03/29/2001WO2001021811A1 Dna immunization against chlamydia infection
03/29/2001WO2001021810A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/29/2001WO2001021809A2 Stachybotrys phenol oxidizing enzyme
03/29/2001WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021790A1 Conditional immortalisation of cells
03/29/2001WO2001021782A2 Enhancer elements for increased translation in plant plastids
03/29/2001WO2001021778A1 A NOVEL TYPE II RESTRICTION ENDONUCLEASE, Hpy99I, OBTAINABLE FROM HELICOBACTER PYLORI J99 AND A PROCESS FOR PRODUCING THE SAME
03/29/2001WO2001021777A1 A NOVEL TYPE II RESTRICTION ENDONUCLEASE, HpyCH4III, OBTAINABLE FROM HELICOBACTER PYLORI CH4 AND A PROCESS FOR PRODUCING THE SAME
03/29/2001WO2001021776A1 A NOVEL TYPE II RESTRICTION ENDONUCLEASE, HpyCH4V, OBTAINABLE FROM HELICOBACTER PYLORI CH4 AND A PROCESS FOR PRODUCING THE SAME
03/29/2001WO2001021775A1 Gene encoding novel human secretory phospholipase a¿2?
03/29/2001WO2001021774A1 Novel transaldolase gene
03/29/2001WO2001021773A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
03/29/2001WO2001021772A2 Methods and microorganisms for production of panto-compounds
03/29/2001WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
03/29/2001WO2001021770A2 Gst sequences from soybean and their use in the production of herbicide resistant plants
03/29/2001WO2001021769A2 THREE-DIMENSIONAL STRUCTURE AND CRYSTAL OF A CLASS I α1,2-MANNOSIDASE, AND METHODS OF USE THEREOF
03/29/2001WO2001021768A1 Site-specific recombination system to manipulate the plastid genome of higher plants
03/29/2001WO2001021764A1 A pcra helicase of staphylococcus aureus
03/29/2001WO2001021761A2 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
03/29/2001WO2001021662A1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium
03/29/2001WO2001021650A2 Cis-prenyltransferases from plants
03/29/2001WO2001021640A1 Identification and functional characterization of a new subfamily of sulfatases
03/29/2001WO2001021638A1 A type ii restriction endonuclease from helicobacter pylori ch4
03/29/2001WO2001021217A2 Method of treating cells of the prostate prophylactically or therapeutically
03/29/2001WO2001005419A3 Agent for treating cardiac diseases
03/29/2001WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins
03/29/2001WO2000077220A3 Method of modifying peptide synthetases such that they can n-methylate their substrate amino acids
03/29/2001WO2000056871A3 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN α-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS
03/29/2001DE19946047A1 Proteinproduktion mit Ashbya gossypii Protein production using Ashbya gossypii
03/29/2001DE19944870A1 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium Signal sequences for preparing Leu-hirudin by E. coli via secretion into the culture medium
03/29/2001DE19937548A1 Ein- oder mehrzellige Organismen zur Herstellung von Riboflavin Mono- or multicellular organisms for the production of riboflavin
03/29/2001CA2793128A1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
03/29/2001CA2387695A1 A novel member of the heparanase protein family
03/29/2001CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385813A1 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
03/29/2001CA2385664A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
03/29/2001CA2385552A1 Phosphatases which activate map kinase pathways
03/29/2001CA2385497A1 Methods and microorganisms for production of panto-compounds
03/29/2001CA2385484A1 Site-specific recombination system to manipulate the plastid genome of higher plants
03/29/2001CA2385406A1 Gene encoding novel human secretory phospholipase a2
03/29/2001CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
03/29/2001CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
03/29/2001CA2384928A1 Method for identifying compounds useful in the therapy of bone disorders
03/29/2001CA2383253A1 Conditional immortalisation of cells
03/29/2001CA2381020A1 Cis-prenyltransferases from plants
03/28/2001EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders
03/28/2001EP1087017A2 The cytoplasmic inhibition of gene expression
03/28/2001EP1087015A2 Cloning and uses of a novel nucleotide sequence coding for glucose-6-phosphate isomerase (gpi) from bacteria
03/28/2001EP1087011A2 Methods for preventing degradation of protein c
03/28/2001EP1086236A2 Polyunsaturated fatty acids in plants